CUX1 in leukemia: Dosage matters

Blood

Volumn 121, Issue 6, 2013, Pages 869-870

  Boultwood, Jacqueline ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CUX1 PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; CHROMOSOME 7; GENE DELETION; GENE INACTIVATION; HAPLOINSUFFICIENCY; HEMATOPOIESIS; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 84873579985     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-12-473421     Document Type: Note

References (10)

1. McNerney ME, Brown CD, Wang X, et al. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood. 2013;121(6):975-983.
2. Fischer K, Frohling S, Scherer SW, et al. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood. 1997;89(6):2036-2041. (Pubitemid 27132119)
3. Le BeauMM,Espinosa R 3rd, Davis EM, Eisenbart JD, Larson RA, Green ED. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood. 1996;88(6):1930-1935. (Pubitemid 26307892)
4. Jerez A, Sugimoto Y, Makishima H, et al. Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis. Blood. 2012;119(25):6109-6117.
5. Largaespada DA. Haploinsufficiency for tumor suppression: the hazards of being single and living a long time. J Exp Med. 2001;193(4):F15-18. (Pubitemid 32524472)
6. Boultwood J, Pellagatti A, McKenzie AN, Wainscoat JS. Advances in the 5q-syndrome. Blood. 2010;116(26):5803-5811.
7. Lewis S, Abrahamson G, Boultwood J, Fidler C, Potter A, Wainscoat JS. Molecular characterization of the 7q deletion in myeloid disorders. Br J Haematol. 1996;93(1):75-80. (Pubitemid 26132389)
8. Hulea L, Nepveu A. CUX1 transcription factors: from biochemical activities and cell-based assays to mouse models and human diseases. Gene. 2012;497(1):18-26.
9. Ernst T, Chase AJ, Score J, et al. Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nat Genet. 2010;42(8):722-726.
10. ThoennissenNH,Lasho T, Thoennissen GB, Ogawa S, Tefferi A, Koeffler HP. NovelCUX1missense mutation in association with 7q-at leukemic transformation of MPN.AmJ Hematol. 2011;86(8):703-705.